Abstract
Antioxidants have gained significant attention in recent years for their potential therapeutic effects in various diseases, including cardiovascular disorders, cancer, neurodegenerative diseases, and diabetes. As free radicals and reactive oxygen species (ROS) play a critical role in cellular damage and disease progression, antioxidants serve as key modulators in preventing oxidative stress. This article explores the role of antioxidants in drug development, examining their mechanisms of action, potential therapeutic benefits, and challenges in integrating antioxidants into clinical treatments. We also discuss the current state of antioxidant-based drug formulations and the future directions for antioxidant therapies in various diseases.
All articles published in the American Journal of Pharmacy and Pharmacology are licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows others to:
-
Share — copy and redistribute the material in any medium or format
-
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Under the following terms:
-
Attribution — Appropriate credit must be given to the original author(s) and source, a link to the license must be provided, and any changes made must be indicated.
By submitting their work, authors agree to these licensing terms and retain copyright of their articles.